Barclays analyst Alex Sloane upgraded Givaudan (GVDNY) to Equal Weight from Underweight with a price target of CHF 4,000, up from CHF 3,800. The firm sees the company as a key potential beneficiary from stepped-up reformulation from 2026 amid the shift to phase out synthetic colors and other ingredients in the U.S.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GVDNY: